Efficacy and safety of single agent capecitabine in pretreated metastatic breast cancer patients from the French compassionate use program.
Pierga JY, Fumoleau P, Brewer Y, Zelek L, Martin D, Turpin FL, Goudier MJ, Gil-Delgado M, Baticle JL, Namer M, Chollet P, Sutherland W, Barats JC; Cooperative Group of the French capecitabine compassionate use program.
Pierga JY, et al.
Breast Cancer Res Treat. 2004 Nov;88(2):117-29. doi: 10.1007/s10549-004-1282-3.
Breast Cancer Res Treat. 2004.
PMID: 15564795
Clinical Trial.